Aurora Kinase B Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Aurora Kinase B market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Aurora Kinase B market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Aurora Kinase B market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Aurora Kinase B market segmented into
- AZD-2811
- CS-2164
- Danusertib
- Ilorasertib
- NMI-900
- Others
- Anaplastic Large Cell Lymphoma
- Kidney Cancer
- Lung Cancer
- Prostate Cancer
- Others
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- AbbVie Inc
- Advenchen Laboratories LLC
- Aeterna Zentaris Inc
- Amgen Inc
- AstraZeneca Plc
- Chipscreen Biosciences Ltd
- Cielo Therapeutics Inc
- Sanofi
- Sareum Holdings Plc
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL AURORA KINASE B INDUSTRY
2.1 Summary about Aurora Kinase B Industry
2.2 Aurora Kinase B Market Trends
2.2.1 Aurora Kinase B Production & Consumption Trends
2.2.2 Aurora Kinase B Demand Structure Trends
2.3 Aurora Kinase B Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 AZD-2811
4.2.2 CS-2164
4.2.3 Danusertib
4.2.4 Ilorasertib
4.2.5 NMI-900
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Anaplastic Large Cell Lymphoma
4.3.2 Kidney Cancer
4.3.3 Lung Cancer
4.3.4 Prostate Cancer
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 AZD-2811
5.2.2 CS-2164
5.2.3 Danusertib
5.2.4 Ilorasertib
5.2.5 NMI-900
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Anaplastic Large Cell Lymphoma
5.3.2 Kidney Cancer
5.3.3 Lung Cancer
5.3.4 Prostate Cancer
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 AZD-2811
6.2.2 CS-2164
6.2.3 Danusertib
6.2.4 Ilorasertib
6.2.5 NMI-900
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Anaplastic Large Cell Lymphoma
6.3.2 Kidney Cancer
6.3.3 Lung Cancer
6.3.4 Prostate Cancer
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 AZD-2811
7.2.2 CS-2164
7.2.3 Danusertib
7.2.4 Ilorasertib
7.2.5 NMI-900
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Anaplastic Large Cell Lymphoma
7.3.2 Kidney Cancer
7.3.3 Lung Cancer
7.3.4 Prostate Cancer
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 AZD-2811
8.2.2 CS-2164
8.2.3 Danusertib
8.2.4 Ilorasertib
8.2.5 NMI-900
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Anaplastic Large Cell Lymphoma
8.3.2 Kidney Cancer
8.3.3 Lung Cancer
8.3.4 Prostate Cancer
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 AZD-2811
9.2.2 CS-2164
9.2.3 Danusertib
9.2.4 Ilorasertib
9.2.5 NMI-900
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Anaplastic Large Cell Lymphoma
9.3.2 Kidney Cancer
9.3.3 Lung Cancer
9.3.4 Prostate Cancer
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AbbVie Inc
10.1.2 Advenchen Laboratories LLC
10.1.3 Aeterna Zentaris Inc
10.1.4 Amgen Inc
10.1.5 AstraZeneca Plc
10.1.6 Chipscreen Biosciences Ltd
10.1.7 Cielo Therapeutics Inc
10.1.8 Sanofi
10.1.9 Sareum Holdings Plc
10.2 Aurora Kinase B Sales Date of Major Players (2017-2020e)
10.2.1 AbbVie Inc
10.2.2 Advenchen Laboratories LLC
10.2.3 Aeterna Zentaris Inc
10.2.4 Amgen Inc
10.2.5 AstraZeneca Plc
10.2.6 Chipscreen Biosciences Ltd
10.2.7 Cielo Therapeutics Inc
10.2.8 Sanofi
10.2.9 Sareum Holdings Plc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL AURORA KINASE B INDUSTRY
2.1 Summary about Aurora Kinase B Industry
2.2 Aurora Kinase B Market Trends
2.2.1 Aurora Kinase B Production & Consumption Trends
2.2.2 Aurora Kinase B Demand Structure Trends
2.3 Aurora Kinase B Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 AZD-2811
4.2.2 CS-2164
4.2.3 Danusertib
4.2.4 Ilorasertib
4.2.5 NMI-900
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Anaplastic Large Cell Lymphoma
4.3.2 Kidney Cancer
4.3.3 Lung Cancer
4.3.4 Prostate Cancer
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 AZD-2811
5.2.2 CS-2164
5.2.3 Danusertib
5.2.4 Ilorasertib
5.2.5 NMI-900
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Anaplastic Large Cell Lymphoma
5.3.2 Kidney Cancer
5.3.3 Lung Cancer
5.3.4 Prostate Cancer
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 AZD-2811
6.2.2 CS-2164
6.2.3 Danusertib
6.2.4 Ilorasertib
6.2.5 NMI-900
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Anaplastic Large Cell Lymphoma
6.3.2 Kidney Cancer
6.3.3 Lung Cancer
6.3.4 Prostate Cancer
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 AZD-2811
7.2.2 CS-2164
7.2.3 Danusertib
7.2.4 Ilorasertib
7.2.5 NMI-900
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Anaplastic Large Cell Lymphoma
7.3.2 Kidney Cancer
7.3.3 Lung Cancer
7.3.4 Prostate Cancer
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 AZD-2811
8.2.2 CS-2164
8.2.3 Danusertib
8.2.4 Ilorasertib
8.2.5 NMI-900
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Anaplastic Large Cell Lymphoma
8.3.2 Kidney Cancer
8.3.3 Lung Cancer
8.3.4 Prostate Cancer
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 AZD-2811
9.2.2 CS-2164
9.2.3 Danusertib
9.2.4 Ilorasertib
9.2.5 NMI-900
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Anaplastic Large Cell Lymphoma
9.3.2 Kidney Cancer
9.3.3 Lung Cancer
9.3.4 Prostate Cancer
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AbbVie Inc
10.1.2 Advenchen Laboratories LLC
10.1.3 Aeterna Zentaris Inc
10.1.4 Amgen Inc
10.1.5 AstraZeneca Plc
10.1.6 Chipscreen Biosciences Ltd
10.1.7 Cielo Therapeutics Inc
10.1.8 Sanofi
10.1.9 Sareum Holdings Plc
10.2 Aurora Kinase B Sales Date of Major Players (2017-2020e)
10.2.1 AbbVie Inc
10.2.2 Advenchen Laboratories LLC
10.2.3 Aeterna Zentaris Inc
10.2.4 Amgen Inc
10.2.5 AstraZeneca Plc
10.2.6 Chipscreen Biosciences Ltd
10.2.7 Cielo Therapeutics Inc
10.2.8 Sanofi
10.2.9 Sareum Holdings Plc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Aurora Kinase B Product Type Overview
2.Table Aurora Kinase B Product Type Market Share List
3.Table Aurora Kinase B Product Type of Major Players
4.Table Brief Introduction of AbbVie Inc
5.Table Brief Introduction of Advenchen Laboratories LLC
6.Table Brief Introduction of Aeterna Zentaris Inc
7.Table Brief Introduction of Amgen Inc
8.Table Brief Introduction of AstraZeneca Plc
9.Table Brief Introduction of Chipscreen Biosciences Ltd
10.Table Brief Introduction of Cielo Therapeutics Inc
11.Table Brief Introduction of Sanofi
12.Table Brief Introduction of Sareum Holdings Plc
13.Table Products & Services of AbbVie Inc
14.Table Products & Services of Advenchen Laboratories LLC
15.Table Products & Services of Aeterna Zentaris Inc
16.Table Products & Services of Amgen Inc
17.Table Products & Services of AstraZeneca Plc
18.Table Products & Services of Chipscreen Biosciences Ltd
19.Table Products & Services of Cielo Therapeutics Inc
20.Table Products & Services of Sanofi
21.Table Products & Services of Sareum Holdings Plc
22.Table Market Distribution of Major Players
23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
25.Table Global Aurora Kinase B Market Forecast (Million USD) by Region 2021f-2026f
26.Table Global Aurora Kinase B Market Forecast (Million USD) Share by Region 2021f-2026f
27.Table Global Aurora Kinase B Market Forecast (Million USD) by Demand 2021f-2026f
28.Table Global Aurora Kinase B Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Aurora Kinase B Product Type Overview
2.Table Aurora Kinase B Product Type Market Share List
3.Table Aurora Kinase B Product Type of Major Players
4.Table Brief Introduction of AbbVie Inc
5.Table Brief Introduction of Advenchen Laboratories LLC
6.Table Brief Introduction of Aeterna Zentaris Inc
7.Table Brief Introduction of Amgen Inc
8.Table Brief Introduction of AstraZeneca Plc
9.Table Brief Introduction of Chipscreen Biosciences Ltd
10.Table Brief Introduction of Cielo Therapeutics Inc
11.Table Brief Introduction of Sanofi
12.Table Brief Introduction of Sareum Holdings Plc
13.Table Products & Services of AbbVie Inc
14.Table Products & Services of Advenchen Laboratories LLC
15.Table Products & Services of Aeterna Zentaris Inc
16.Table Products & Services of Amgen Inc
17.Table Products & Services of AstraZeneca Plc
18.Table Products & Services of Chipscreen Biosciences Ltd
19.Table Products & Services of Cielo Therapeutics Inc
20.Table Products & Services of Sanofi
21.Table Products & Services of Sareum Holdings Plc
22.Table Market Distribution of Major Players
23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
25.Table Global Aurora Kinase B Market Forecast (Million USD) by Region 2021f-2026f
26.Table Global Aurora Kinase B Market Forecast (Million USD) Share by Region 2021f-2026f
27.Table Global Aurora Kinase B Market Forecast (Million USD) by Demand 2021f-2026f
28.Table Global Aurora Kinase B Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Aurora Kinase B Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Aurora Kinase B Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Aurora Kinase B Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Aurora Kinase B Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Aurora Kinase B Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Aurora Kinase B Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Aurora Kinase B Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure AZD-2811 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure CS-2164 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Danusertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Ilorasertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure NMI-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Anaplastic Large Cell Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure AZD-2811 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure CS-2164 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Danusertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Ilorasertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure NMI-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Anaplastic Large Cell Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure AZD-2811 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure CS-2164 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Danusertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Ilorasertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure NMI-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Anaplastic Large Cell Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure AZD-2811 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure CS-2164 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Danusertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Ilorasertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure NMI-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Anaplastic Large Cell Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
75.Figure AZD-2811 Segmentation Market Size (US
1.Figure Global Aurora Kinase B Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Aurora Kinase B Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Aurora Kinase B Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Aurora Kinase B Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Aurora Kinase B Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Aurora Kinase B Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Aurora Kinase B Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure AZD-2811 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure CS-2164 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Danusertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Ilorasertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure NMI-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Anaplastic Large Cell Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure AZD-2811 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure CS-2164 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Danusertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Ilorasertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure NMI-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Anaplastic Large Cell Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure AZD-2811 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure CS-2164 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Danusertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Ilorasertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure NMI-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Anaplastic Large Cell Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure AZD-2811 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure CS-2164 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Danusertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Ilorasertib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure NMI-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Anaplastic Large Cell Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Kidney Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
75.Figure AZD-2811 Segmentation Market Size (US
